Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia

BackgroundAlthough chronic urticaria (CU) is a common, cause of medical consulting both in general practitioners and allergist specialists worldwide, there is little information about its behavior and management in Latin America. Currently, national and international guidelines recommend using Omali...

Descripció completa

Dades bibliogràfiques

Autors principals:	Elizabeth García-Gómez, Edgardo Chapman, María Beatriz García-Paba, Jaime Ocampo-Gómez, Eduardo Egea-Bermejo, Gloria Garavito-De Egea, Luis Fang, Mauricio Sarrazola, Jorge Mario Sánchez-Caraballo, Carlos Serrano-Reyes, Diana Lucia Silva-Espinosa, Dolly Vanessa Rojas-Mejía, Sergio M. Moreno
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2022-05-01
Col·lecció:	Frontiers in Allergy
Matèries:	urticaria angioedema Omalizumab inducible antihistamines
Accés en línia:	https://www.frontiersin.org/articles/10.3389/falgy.2022.902344/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!